Cited by 731Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementCardiovascular and Diving-Related Complications

The DOI matches its Crossref record; 254 of the 256 references it cites were found in a registry or an index.

Global epidemiology of atrial fibrillation

Rahman, Faisal, Kwan, Gene F., Benjamin, Emelia J.·2014·Nature Reviews Cardiology

DOI 10.1038/nrcardio.2014.118

Open this paper in CoChat — free account

Abstract

Atrial fibrillation (AF) is a major public health burden worldwide, and its prevalence is set to increase owing to widespread population ageing, especially in rapidly developing countries such as Brazil, China, India, and Indonesia. Despite the availability of epidemiological data on the prevalence of AF in North America and Western Europe, corresponding data are limited in Africa, Asia, and South America. Moreover, other observations suggest that the prevalence of AF might be underestimated-not only in low-income and middle-income countries, but also in their high-income counterparts. Future studies are required to provide precise estimations of the global AF burden, identify important risk factors in various regions worldwide, and take into consideration regional and ethnic variations in AF. Furthermore, in response to the increasing prevalence of AF, additional resources will need to be allocated globally for prevention and treatment of AF and its associated complications. In this Review, we discuss the available data on the global prevalence, risk factors, management, financial costs, and clinical burden of AF, and highlight the current worldwide inadequacy of its treatment.

Integrity signals

Registry

Crossref · 10.1038/nrcardio.2014.118

Cites

254 of 254 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Self-citation
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Self-citation
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Global burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319

Show all 256 references

Research works printed but not linked: 5

Einthoven, W. Le telecardiogramme [French]. Arch. Int. Physiol. 4, 132–164 (1906).
Guize, L., Thomas, F., Bean, K., Benetos, A. & Pannier, B. Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up [French]. Bull. Acad. Natl Med. 191, 791–803 (2007).
Maurice, M. F., Di Tommaso, F., Zgaig, M., Stutzbach, P. & Iglesias, R. Thromboprophylaxis of atrial fibrillation. Analysis of the Argentinean National Register of Atrial Fibrillation and Atrial Flutter (RENAFA) [abstract]. J. Cardiovasc. Electrophysiol. 22 (Suppl. 1), S102 (2011).
Rasool, S. & Haq, Z. Anticoagulation therapy in high risk patients with atrial fibrillation: retrospective study in a regional hospital. JLUMHS 8, 136–138 (2009).
Arce, M. et al. Frecuencia de fibrilación auricular y tratamiento con anticoagulantes orales en pacientes con marcapasos definitivo [Spanish]. Invest. Clin. 52, 58–68 (2011).

Sorted by citations

European Society of Cardiology: cardiovascular disease statistics 2021
Timmis, A., Vardas, P. E., Townsend, N. P., Torbica, A., Katus, H. A., Smedt, D. D., Gale, C. P., Maggioni, A. P., Petersen, S. E., Huculeci, R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab892 · Cited by 1,235
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study
Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V., & Rosenqvist, M. (2015) · Circulation · doi:10.1161/circulationaha.114.014343 · Cited by 605
Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients
Romiti, G. F., Pastori, D., Rivera‐Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., Gumprecht, J. J., Kozieł, M., Yang, P., Guo, Y., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1515-9630 · Cited by 430
A major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 422
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.45 · Cited by 353
Self-citation
Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation
Wong, C. X. J., Sullivan, T., Sun, M. T., Mahajan, R., Pathak, R. K., Middeldorp, M. E., Twomey, D. J., Ganesan, A. N., Rangnekar, G., Roberts‐Thomson, K. C., et al. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.04.004 · Cited by 354
Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017
Dai, H., Zhang, Q., Abu‐Much, A., Maor, E., Segev, A., Beinart, R., Adawi, S., Lu, Y., Bragazzi, N. L., & Wu, J. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa061 · Cited by 339
Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
Goette, A., Corradi, D., Dobrev, D., Aguinaga, L., Cabrera, J. Á., Chugh, S. S., de Groot, J. R., Soulat-Dufour, L., Fenelon, G., Hatem, S. N., et al. (2024) · EP Europace · doi:10.1093/europace/euae204 · Cited by 370
Cardiovascular disease in Africa: epidemiological profile and challenges
Keates, A. K., Mocumbi, A. O., Ntsekhe, M., Sliwa, K. S., & Stewart, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.19 · Cited by 340
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P. E., Townsend, N. P., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 371
Atrial fibrillation: the current epidemic.
Morillo, C. A., Banerjee, A., Perel, P., Wood, D. A., & Jouven, X. (2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.03.011 · Cited by 317
The changing face of cardiovascular disease 2000–2012: An analysis of the world health organisation global health estimates data
McAloon, C. J., Boylan, L. M., Hamborg, T., Stallard, N., Osman, F., Lim, P. B., & Hayat, S. A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.026 · Cited by 281
The Epidemiology of Atrial Fibrillation and Stroke
Pistoia, F., Sacco, S., Tiseo, C., Degan, D., Ornello, R., & Carolei, A. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.002 · Cited by 244
Epidemiology of atrial fibrillation
Zulkifly, H. H., Lip, G. Y. H., & Lane, D. A. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13070 · Cited by 242
Atrial fibrillation
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Gelder, I. C. V., Natale, A., Gianni, C., Nattel, S., Potpara, T., Rienstra, M., Tse, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.16 · Cited by 248
Inflammation and atrial fibrillation: A comprehensive review
Korantzopoulos, P. G., Letsas, Κ. P., Tse, G., Fragakis, N., Goudis, C. A., & Liu, T. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12077 · Cited by 230
Thrombectomy Outcomes of Intracranial Atherosclerosis-Related Occlusions.
Tsang, A., Orru', E., Klostranec, J., Yang, I.-H., Lau, K.-K., Tsang, F. C., Wai, M.-L., Pereira, V., & Krings, T. (2019) · Stroke · doi:10.1161/strokeaha.119.024889 · Cited by 171
Severity of OSA Is an Independent Predictor of Incident Atrial Fibrillation Hospitalization in a Large Sleep-Clinic Cohort
Cadby, G., McArdle, N., Briffa, T., Hillman, D. R., Simpson, L., Knuiman, M., & Hung, J. (2015) · Chest · doi:10.1378/chest.15-0229 · Cited by 184
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Lip, G. Y. H., Proietti, M., Potpara, T., MANSOUR, M. C., Savelieva, I., Tse, H., Goette, A., Camm, A. J., Blomström‐Lundqvist, C., Gupta, D., et al. (2023) · EP Europace · doi:10.1093/europace/euad226 · Cited by 176
A deep learning approach to monitoring and detecting atrial fibrillation using wearable technology
Shashikumar, S. P., Shah, A. J., Qiao, L., Clifford, G. D., & Nemati, S. (2017) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi.2017.7897225 · Cited by 167
Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population
Lee, S., Choi, E., Han, K., Cha, M., & Oh, S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.039 · Cited by 165
Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation
Chao, T., Liu, C., Tuan, T., Chen, T., HSIEH, M., Lip, G. Y. H., & Chen, S.-A. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.10.001 · Cited by 163
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.04.017 · Cited by 160
SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
Li, W.-J., Chen, X.-Q., Xu, L., Li, Y., & Luo, B. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01105-5 · Cited by 166
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
Fanola, C. L., Ruff, C. T., Murphy, S. A., Jin, J., Duggal, A., Babilonia, N. A., Sritara, P., Mercuri, M. F., Kamphuisen, P. W., Antman, E. M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008987 · Cited by 156
Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links
Goudis, C. A., Korantzopoulos, P. G., Ntalas, I. V., Kallergis, E. M., & Ketikoglou, D. G. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.04.002 · Cited by 154
ECG signal classification based on deep CNN and BiLSTM
Cheng, J., Zou, Q., & Zhao, Y. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01736-y · Cited by 168
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias
Scott, L., Fender, A. C., Saljic, A., Li, L., Chen, X., Wang, X., Linz, D., Lang, J., Hohl, M., Twomey, D. J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab024 · Cited by 154
Geographic variations in the PARADIGM-HF heart failure trial
Kristensen, S. L., Martínez, F., Jhund, P. S., Arango, J. L., Bělohlávek, J., Boytsov, S. A., Cabrera, W., Gómez, E. A., Hagège, A. A., Huang, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw226 · Cited by 139
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
Lip, G. Y. H., Collet, J., Caterina, R. D., Fauchier, L., Lane, D. A., Larsen, T. B., Marín, F. R., Morais, J., Narasimhan, C., Olshansky, B., et al. (2017) · EP Europace · doi:10.1093/europace/eux240 · Cited by 141
The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey
Wang, Z., Chen, Z., Wang, X., Zhang, L., Li, S., Tian, Y., Shao, L., Hu, H., & Gao, R. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.05.015 · Cited by 130
Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies
Goudis, C. A., Korantzopoulos, P. G., Ntalas, I. V., Kallergis, E. M., Liu, T., & Ketikoglou, D. G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.052 · Cited by 133
Control de la anticoagulación en pacientes con fibrilación auricular no valvular asistidos en atención primaria en España. Estudio PAULA
Barrios, V., Escobar, C., Prieto, L., Osorio, G., Polo, J., Lobos, J. M., Vargas, D., & García, N. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.04.017 · Cited by 131
Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke
Lin, K., Fan, F., Cai, M.-Q., Yin, Y., Fu, C., Ding, L.-Y., Sun, Y.-D., Sun, J.-W., Shi, Y.-W., Dong, Z., et al. (2022) · European journal of medical research · doi:10.1186/s40001-022-00733-9 · Cited by 130
Atrial fibrillation and stroke
Choi, S. E., Sagris, D., Hill, A. M., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2160319 · Cited by 142
Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
Jani, B., Nicholl, B. I., McQueenie, R., Connelly, D. T., Hanlon, P., Gallacher, K., Lee, D., & Mair, F. S. (2017) · EP Europace · doi:10.1093/europace/eux322 · Cited by 118
Atrial fibrillation, antithrombotic treatment, and cognitive aging
Ding, M., Fratiglioni, L., Johnell, K., Santoni, G., Fastbom, J., Ljungman, P. L. S., Marengoni, A., & Qiu, C. (2018) · Neurology · doi:10.1212/wnl.0000000000006456 · Cited by 115
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017
Wang, L., Ze, F., Li, J., Mi, L., Han, B., Niu, H., & Zhao, N. (2020) · Heart · doi:10.1136/heartjnl-2020-317656 · Cited by 114
Contact‐Free Screening of Atrial Fibrillation by a Smartphone Using Facial Pulsatile Photoplethysmographic Signals
Yan, B. P., Lai, W. H., Chan, C. K. Y., Chan, S. C., Chan, L.-H., Lam, K., Lau, H., Ng, C., Tai, L., Yip, K., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008585 · Cited by 112
Edoxaban in Asian Patients With Atrial Fibrillation
Lee, S., Choi, E., Han, K., Jung, J., Oh, S., & Lip, G. Y. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.066 · Cited by 112
Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke
Zou, R., Zhang, D., Lv, L., Shi, W., Song, Z., Yi, B., Lai, B., Chen, Q., Yang, S., & Hua, P. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1790-x · Cited by 109
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
Mantovani, A., Ballestri, S., Lonardo, A., & Targher, G. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4040-6 · Cited by 109
Long working hours as a risk factor for atrial fibrillation: a multi-cohort study
Mika Kivimaki, B., Nyberg, S. T., Batty, G. D., Kawachi, I. I., Jokela, M. M., Alfredsson, L. S., Bjørner, J. B., Borritz, M., Burr, H., Dragano, N., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx324 · Cited by 114
Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., Bruno, A. S., & Phatak, H. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12863 · Cited by 106
C 2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study
Li, Y., Bisson, A., Bodin, A., Herbert, J., Grammatico‐Guillon, L., Joung, B., Wang, Y., Lip, G. Y. H., & Fauchier, L. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012546 · Cited by 102
Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use
Proietti, M., Marzona, I., Vannini, T., Tettamanti, M., Fortino, I., Merlino, L. G., Basili, S., Mannucci, P. M., Boriani, G., Lip, G. Y. H., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.06.012 · Cited by 103
Oxidative stress and atrial fibrillation: an update
Korantzopoulos, P. G., Letsas, Κ. P., Fragakis, N., Tse, G., & Liu, T. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1500696 · Cited by 98
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Alamneh, E. A., Chalmers, L., & Bereznicki, L. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0161-8 · Cited by 98
Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
Gumprecht, J. J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0279-7 · Cited by 98
Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation
Fenger‐Grøn, M., Overvad, K., Tjønneland, A. M., & Frost, L. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.558 · Cited by 96
Diagnostic Accuracy of Smartwatches for the Detection of Cardiac Arrhythmia: Systematic Review and Meta-analysis
Nazarian, S., Lam, K., Darzi, A. W., & Ashrafian, H. (2021) · Journal of Medical Internet Research · doi:10.2196/28974 · Cited by 101
Left Atrial Function Predicts Atrial Arrhythmia Recurrence Following Ablation of Long-Standing Persistent Atrial Fibrillation
Khan, H. R., Yakupoglu, H. Y., Kralj‐Hans, I., Haldar, S., Bahrami, T. T., Clague, J. R., Souza, A. D., Hussain, W., Jarman, J. W. E., Jones, D. G., et al. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.015352 · Cited by 87
The Impact of Frailty on Mortality, Length of Stay and Re-hospitalisation in Older Patients with Atrial Fibrillation
Nguyen, T. N., Cumming, R. G., & Hilmer, S. N. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.12.002 · Cited by 83
Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation
Law, S. W. Y., Lau, W. C. Y., Wong, I. C. K., Lip, G. Y. H., Mok, M. T. C., Siu, C., & Chan, E. W. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.066 · Cited by 82
Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
Zheng, R., Wang, Y., Tang, J., Duan, J.-Y., Yuan, M.-Y., & Zhang, J. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001183 · Cited by 90
Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey
Wang, X., Fu, Q., Song, F., Li, W., Yin, X., Yue, W., Yan, F., Zhang, H., Zhang, H., Teng, Z., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.131 · Cited by 79
TRP channels in cardiac and intestinal fibrosis
Inoue, R., Kurahara, L. H., & Hiraishi, K. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.11.002 · Cited by 78
The Blinding Period Following Ablation Therapy for Atrial Fibrillation
Gottlieb, L. A., Dekker, L., & Coronel, R. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.01.011 · Cited by 80
miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation
Cañón, S., Caballero, R., Herraiz‐Martínez, A., Pérez-Hernández, M., López, B., Atienza, F., Jalife, J., Hove‐Madsen, L., Delpón, E., & Bernad, A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.08.012 · Cited by 74
Outcomes of Rescue Endovascular Treatment of Emergent Large Vessel Occlusion in Patients With Underlying Intracranial Atherosclerosis: Insights From STAR
Kasab, S. A., Almallouhi, E., Alawieh, A. M., Wolfe, S. Q., Fargen, K. M., Arthur, A. S., Goyal, N., Dumont, T. M., Kan, P. T. M., Kim, J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020195 · Cited by 72
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
Stambler, B. S., & Ngunga, L. M. (2015) · International Journal of General Medicine · doi:10.2147/ijgm.s84537 · Cited by 73
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation
Nyong, J., Amit, G., Adler, A. J., Owolabi, O., Perel, P., Prieto‐Merino, D., Lambiase, P. D., Casas, J. P., & Morillo, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012088.pub2 · Cited by 75
Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
da Silva, R. M. F. L., Miranda, C. M., Liu, T., Tse, G., & Roever, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00018 · Cited by 74
Effect of oral anticoagulant use on surgical delay and mortality in hip fracture
You, D., Xu, Y., Ponich, B., Ronksley, P. E., Skeith, L., Korley, R., Carrier, M., & Schneider, P. (2021) · The Bone & Joint Journal · doi:10.1302/0301-620x.103b2.bjj-2020-0583.r2 · Cited by 69
Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study
Rahman, F., Yin, X., Larson, M. G., Ellinor, P. T., Lubitz, S. A., Vasan, R. S., McManus, D. D., Magnani, J. W., & Benjamin, E. J. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07683 · Cited by 68
Self-citation
Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis
Mantovani, A. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00005 · Cited by 68
Stroke Prevention in Nonvalvular Atrial Fibrillation
Alkhouli, M. A., Noseworthy, P. A., Rihal, C. S., & Holmes, D. R. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.013 · Cited by 70
Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study
Ahn, H., Lee, S., Choi, E., Han, K., Jung, J., Lim, J., Yun, J. P., Kwon, S., Oh, S., & Lip, G. Y. H. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003659 · Cited by 71
Personalized computational modeling of left atrial geometry and transmural myofiber architecture
Fastl, T. E., Tobon‐Gomez, C., Crozier, A., Whitaker, J., Rajani, R., McCarthy, K. P., Sánchez‐Quintana, D., Ho, S. Y., O'Neill, M. D., Plank, G., et al. (2018) · Medical Image Analysis · doi:10.1016/j.media.2018.04.001 · Cited by 67
Causal Effect of Obstructive Sleep Apnea on Atrial Fibrillation: A Mendelian Randomization Study
Chen, W., Cai, X., Yan, H., & Pan, Y. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022560 · Cited by 65
Atrial fibrillation: prevalence in a large database of primary care patients in Brazil
Marcolino, M. S., Moore-Palhares, D., Benjamin, E. J., & Ribeiro, A. L. P. (2015) · EP Europace · doi:10.1093/europace/euv185 · Cited by 66
Self-citation
Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort
Son, M. K., Lim, N.-K., Kim, H. W., & Park, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179687 · Cited by 67
Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study
Lee, S., Choi, E., Ahn, H., Han, K., Oh, S., & Lip, G. Y. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-75822-y · Cited by 64
Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review
Yenikomshian, M. A., Jarvis, J. L., Patton, C., Yee, C. W., Mortimer, R., Birnbaum, H. G., & Topash, M. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1610370 · Cited by 61
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
Pinho‐Gomes, A., Azevedo, L. F., Copland, E., Canoy, D., Nazarzadeh, M., Ramakrishnan, R., Berge, E., Sundström, J., Kotecha, D., Woodward, M., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003599 · Cited by 62
Sensitivity Analysis of In Silico Fluid Simulations to Predict Thrombus Formation after Left Atrial Appendage Occlusion
Mill, J., Agudelo, V. H., Olivares, A. L., Pons, M. I., Silva, E., Nuñez‐Garcia, M., Morales, X., Arzamendi, D., Freixa, X., Noailly, J., et al. (2021) · Mathematics · doi:10.3390/math9182304 · Cited by 59
Same‐day discharge in selected patients undergoing atrial fibrillation ablation
Bartoletti, S., Mann, M., Gupta, A., Khan, A. M., Sahni, A., Kadri, M. E., Modi, S. S., Waktare, J. E. P., Mahida, S., Hall, M. C. S., et al. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13807 · Cited by 58
Atrial fibrillation in low- and middle-income countries: a narrative review
Santos, I. S., Goulart, A. C., Olmos, R. D., Thomas, G. N., Lip, G. Y. H., Lotufo, P. A., Benseñor, I. M., the NIHR Global Health Group on Atrial Fibrillation Management, Arasalingam, A., Benseñor, I. M., et al. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa181 · Cited by 60
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy
Wiedmann, F., Beyersdorf, C., Zhou, X.-B., Kraft, M., Paasche, A., Jávorszky, N., Rinné, S., Sutanto, H., Büscher, A., Foerster, K. I., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab177 · Cited by 56
Racial and Ethnic Differences in the Management of Atrial Fibrillation
Tamirisa, K. P., Al‐Khatib, S. M., Mohanty, S., Han, J. K., Natale, A., Gupta, D., Russo, A. M., Al‐Ahmad, A., Gillis, A. M., & Thomas, K. L. (2021) · CJC Open · doi:10.1016/j.cjco.2021.09.004 · Cited by 57
Depression, antidepressants, and the risk of non-valvular atrial fibrillation: A nationwide Danish matched cohort study
Fenger‐Grøn, M., Vestergaard, M., Pedersen, H. S., Frost, L., Parner, E. T., Ribe, A. R., & Davydow, D. S. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318811184 · Cited by 55
Human Epicardial Adipose Tissue cTGF Expression is an Independent Risk Factor for Atrial Fibrillation and Highly Associated with Atrial Fibrosis
Wang, Q., Wang, X., Yin, L., Wang, J., Shen, H. M., Gao, Y., Min, J., Zhang, Y., & Wang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-21911-y · Cited by 54
Epidemiological Characteristics of Atrial Fibrillation in Southern China: Results from the Guangzhou Heart Study
Deng, H., Guo, P., Zheng, M., Huang, J., Xue, Y., Zhan, X., Wang, F., Liu, Y., Fang, X., Liao, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35928-w · Cited by 54
Body composition and atrial fibrillation: a Mendelian randomization study
Tikkanen, E., Gustafsson, S., Knowles, J. W., Perez, M. V., Burgess, S., & Ingelsson, E. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz003 · Cited by 53
The World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation
Murphy, A., Banerjee, A., BREITHARDT, G. E., Camm, A. J., Commerford, P., Freedman, B., González-Hermosillo, J. A., Halperin, J. L., Lau, C., Perel, P., et al. (2017) · Global Heart · doi:10.1016/j.gheart.2017.01.015 · Cited by 53
Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations
Zheng, Y., Xie, Z., Li, J., Chen, C., Cai, W., Dong, Y., Xue, R., & Liu, C. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01858-1 · Cited by 53
Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK Biobank and Korean NHIS-HEALS cohort studies
Kim, M.-H., Yang, P., Kim, D., Jang, E., Yu, H. T., Kim, T.-H., Sung, J., Pak, H., Lee, M., Lip, G. Y. H., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.02.013 · Cited by 51
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
Hajhosseiny, R., Matthews, G. D. K., & Lip, G. Y. H. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.038 · Cited by 53
Association of Atrial Fibrillation and Cancer
Rahman, F., Ko, D., & Benjamin, E. J. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0582 · Cited by 51
Self-citation
Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
Nochaiwong, S., Ruengorn, C., Awiphan, R., Dandecha, P., Noppakun, K., & Phrommintikul, A. (2016) · Open Heart · doi:10.1136/openhrt-2016-000441 · Cited by 52
Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study
Soni, A., Karna, S., Fahey, N., Sanghai, S., Patel, H. A., Raithatha, S. J., Thanvi, S., Nimbalkar, S. M., Freedman, B., Allison, J. J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.12.016 · Cited by 50
Atrial Fibrillation and Stroke
Essa, H., Hill, A. M., & Lip, G. Y. H. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.003 · Cited by 53
Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study
Barrios, V., Escobar, C., Prieto, L., Osorio, G., Polo, J., Lobos, J. M., Vargas, D., & García, N. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.04.017 · Cited by 48
Risk factors for new-onset atrial fibrillation: A focus on Asian populations
Li, Y., Pastori, D., Guo, Y., Wang, Y., & Lip, G. Y. H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.051 · Cited by 49
Atrial Fibrillation, Stroke, and Silent Cerebrovascular Disease
Rydén, L., Sacuiu, S. F., Wetterberg, H., Najar, J., Guo, X., Kern, S., Zettergren, A., Shams, S., Pereira, J. B., Wahlund, L., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012675 · Cited by 48
Erratum: Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.114 · Cited by 48
Self-citation
Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring
Liu, C., Chang, S., Yeh, Y., Chung, F., Hu, Y., Chou, C.-C., Hung, K., Chang, P., Liao, J., Chan, Y., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.03.015 · Cited by 49
Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia
Greer-Short, A., Musa, H., Alsina, K. M., Ni, L., Word, T. A., Reynolds, J. O., Gratz, D. H., Lane, C., Refaey, M. E., Unudurthi, S. D., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.10.016 · Cited by 47
Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts
Karakasis, P., Theofilis, P., Vlachakis, P. K., Ktenopoulos, N., Patoulias, D., Antoniadis, A. P., & Fragakis, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093250 · Cited by 53
Application of Static Modeling in the Prediction of In Vivo Drug–Drug Interactions between Rivaroxaban and Antiarrhythmic Agents Based on In Vitro Inhibition Studies
Cheong, E. J. Y., Goh, J. J. N., Hong, Y., Venkatesan, G., Liu, Y., Chiu, G. N. C., Kojodjojo, P., & Chan, E. C. Y. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.073890 · Cited by 46

Authors: Rahman, F., Kwan, G. F., & Benjamin, E. J.
Affiliations: Boston University (US)
Framingham Heart Study (US)
Corresponding author: Benjamin, Emelia J.
ORCID: Rahman, Faisal
Kwan, Gene F.
Benjamin, Emelia J.
Venue: Nature Reviews Cardiology
Publisher: Springer Science and Business Media LLC
Published: 2014-08-12
Volume: 11
Issue: 11
Pages: 639-654
ISSN: 1759-5002 (ISSN-L)
1759-5010
DOI: 10.1038/nrcardio.2014.118
OpenAlex: W2066466450
Cited by: 731
References: 256
Citations by year: 2026: 14 · 2025: 34 · 2024: 72 · 2023: 76 · 2022: 85 · 2021: 104 · 2020: 80 · 2019: 67 · 2018: 55 · 2017: 55 · 2016: 54 · 2015: 33 · 2014: 1
FWCI: 7.59
Type: journal article
Language: en
Update notices: erratum (2016-07-14)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
Keywords: atrial fibrillation, global prevalence, population aging, underestimation of prevalence, risk factors, financial costs, clinical burden, low- and middle-income countries, public health burden
MeSH terms: Atrial Fibrillation, Humans, Risk Factors, Global Health, Prevalence, Cost of Illness, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global epidemiology of atrial fibrillation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks